Abstract:Abstract Introduction Prostate cancer (PCa), an androgen-dependent tumor and one of the most prevalent cancers in males, has traditionally been treated with androgen suppression. In recent years, bipolar androgen treatment (BAT) has emerged as a potential therapeutic approach for men with metastatic castrate-resistant PCa. The control of testosterone (T) between castration and supraphysiological levels inhibits the proliferation of cancer cells and slows the progression of cancer. Furthermore, while there has been prior research between T and erectile function, there is no evidence linking BAT and erectile dysfunction (ED). Objective The purpose of the current investigation was to determine if BAT therapy was effective in treating ED in a castration-prone rat model. Methods Sprague-Dawley rats (n=30) were randomly divided into four groups: 1) Control, 2) Control rats-received BAT treatment, 3) castrated Rats, and 4) castrated rats-received BAT treatment. The rats were castrated by making bilateral scrotal incisions. A subcutaneous injection of testosterone propionate (250 mg/kg/week, intramuscular) was administered four weeks following castration. Four weeks after the initial dose, the second dose of the medication was given in the same manner. By stimulating the cavernous nerve, the intracavernosal pressure (ICP) to mean arterial pressure (MAP) ratio and total ICP were determined. Corpus cavernosum (CC) strips were used as in vitro preparations for evaluating the relaxant and contractile responses. Nitric oxide synthase (nNOS) and endothelial NOS (eNOS) protein expression was analyzed using Western blotting. Using Masson trichrome staining, the location of the smooth muscle in relation to the collagen was identified. Results Castrated rats' prostate weight was reduced when compared to uncastrated rats (P< 0.001). Compared to controls and castrated rats, BAT marginally boosted prostate weight reduction. The ICP/MAP ratio and total ICP for 7.5 V were lowest in castrated rats (P< 0.001 vs. controls). BAT enhanced ICP/MAP and total ICP responses (P<0.01 vs. castrated rats). In vitro, endothelium-dependent acetylcholine-induced relaxation at 1 nM (P 0.05 vs controls), endothelium-independent sodium nitroprusside-induced relaxation at 1 nM (P 0.01 vs controls), electrical field stimulation-induced relaxant response at 20 Hz (P<0.05 vs. controls) and sildenafil-induced relaxation at 10 M (P 0.05 vs controls) were all reduced in the CC strips from the castrated group. Additionally, the castrated group showed increased neurogenic contractile response at 40 Hz and the contractile response to phenylephrine at 1 mM (P 0.001 vs. controls). The variations in the relaxation and contractile responses were returned by BAT. The smooth muscle cell-to-collagen ratio and nNOS and eNOS protein expression were both markedly reduced in castrated rats, though BAT reversed these modifications. Conclusions The results of the study show that BAT improves neurogenic relaxation, endothelium relaxation, sildenafil-induced relaxing of the CC, and changes in penile morphology after castration. BAT might be a cutting-edge therapeutic approach for patients with castration-resistant prostate cancer who have an ED route. Disclosure No.

Castration Impairs Erectile Organ Structure and Function by Inhibiting Autophagy and Promoting Apoptosis of Corpus Cavernosum Smooth Muscle Cells in Rats.

Phenotypic modulation of corpus cavernosum smooth muscle cells in a rat model of cavernous neurectomy.

Apoptosis in Rat Erectile Tissue Induced by Castration.

Study on apoptosis in the rate erectile tissue after castration

Androgen Deficiency Impairs Erectile Function in Rats Through Promotion of Corporal Fibrosis

Low Androgen Status Inhibits Erectile Function by Increasing Pyroptosis in Rat Corpus Cavernosum.

Effect Of Androgen Deprivation On Penile Ultrastructure

Low Androgen Status Inhibits Erectile Function by Up‐regulating the Expression of P2X Receptors in Rat Corpus Cavernosum

(066) A Low Androgen State Impairs Erectile Function by Suppressing EPAC1 in Rat Corpus Cavernosum Penis

Hypoxia-Induced Phenotypic Transformation of Corpus Cavernosum Smooth Muscle Cells after Cavernous Nerve Crush Injury by Down-Regulating P38 Mitogen-Activated Protein Kinase Expression

The Platelet-Derived Growth Factor Receptor/stat3 Signaling Pathway Regulates the Phenotypic Transition of Corpus Cavernosum Smooth Muscle in Rats.

A low androgenic state inhibits erectile function by suppressing endothelial glycosides in the penile cavernous tissue of rats

Panaxnotoginsengsaponin improves erectile function by inducing autophagy , inhibiting apoptosis , and increasing connexin 43 phosphorylation

Effect of Platelet-Derived Growth Factor-Bb on Gap Junction and Connexin43 in Rat Penile Corpus Cavernosum Smooth Muscle Cells.

A low testosterone level impairs erectile function by increasing endocan expression in rat penile corpus cavernosum

Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function by inducing apoptosis in a rat model of experimental autoimmune prostatitis

Effects of endoplasmic reticulum stress on erectile function in rats with cavernous nerve injury

Changes in Erectile Organ Structure and Function in a Rat Model of Chronic Prostatitis/chronic Pelvic Pain Syndrome.

(247) A Rat Model for Bipolar Androgen Therapy is Evaluated for Its Effects on Erectile Dysfunction after Castration

Chronic Prostatitis/chronic Pelvic Pain Syndrome Impairs Erectile Function Through Increased Endothelial Dysfunction, Oxidative Stress, Apoptosis, and Corporal Fibrosis in a Rat Model

Corpus Cavernosum Smooth Muscle Cell Dysfunction and Phenotype Transformation Are Related to Erectile Dysfunction in Prostatitis Rats with Chronic Prostatitis/chronic Pelvic Pain Syndrome